82 related articles for article (PubMed ID: 10782995)
1. 'In vitro evolution' of ligands for HCV-specific serum antibodies.
Zhu ZY; Minenkova O; Bellintani F; De Tomassi A; Urbanelli L; Felici F; Monaci P
Biol Chem; 2000 Mar; 381(3):245-54. PubMed ID: 10782995
[TBL] [Abstract][Full Text] [Related]
2. "Affinity maturation" of ligands for HCV-specific serum antibodies.
Urbanelli L; Fortugno P; Bartoli F; Nuzzo M; De Tomassi A; Felici F; Monaci P
J Immunol Methods; 2000 Mar; 236(1-2):167-76. PubMed ID: 10699588
[TBL] [Abstract][Full Text] [Related]
3. Identification of peptide sequences specific for serum antibodies from human papillomavirus-infected patients using phage display libraries.
Santamaria H; Manoutcharian K; Rocha L; Gonzalez E; Acero G; Govezensky T; Uribe LI; Olguin A; Paniagua J; Gevorkian G
Clin Immunol; 2001 Dec; 101(3):296-302. PubMed ID: 11726222
[TBL] [Abstract][Full Text] [Related]
4. DNA-based selection and screening of peptide ligands.
Bartoli F; Nuzzo M; Urbanelli L; Bellintani F; Prezzi C; Cortese R; Monaci P
Nat Biotechnol; 1998 Nov; 16(11):1068-73. PubMed ID: 9831038
[TBL] [Abstract][Full Text] [Related]
5. Selection of a phage-displayed peptide recognized by monoclonal antibody directed blocking the site of hepatitis C virus E2 for human CD81.
Cao J; Liao XL; Wu SM; Zhao P; Zhao LJ; Wu WB; Qi ZT
J Microbiol Methods; 2007 Mar; 68(3):601-4. PubMed ID: 17178166
[TBL] [Abstract][Full Text] [Related]
6. Selection of tumor-binding ligands in cancer patients with phage display libraries.
Krag DN; Shukla GS; Shen GP; Pero S; Ashikaga T; Fuller S; Weaver DL; Burdette-Radoux S; Thomas C
Cancer Res; 2006 Aug; 66(15):7724-33. PubMed ID: 16885375
[TBL] [Abstract][Full Text] [Related]
7. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains.
van den Beucken T; van Neer N; Sablon E; Desmet J; Celis L; Hoogenboom HR; Hufton SE
J Mol Biol; 2001 Jul; 310(3):591-601. PubMed ID: 11439026
[TBL] [Abstract][Full Text] [Related]
8. Identification of epitopes in the nucleocapsid protein of Nipah virus using a linear phage-displayed random peptide library.
Eshaghi M; Tan WS; Yusoff K
J Med Virol; 2005 Jan; 75(1):147-52. PubMed ID: 15543570
[TBL] [Abstract][Full Text] [Related]
9. Identification of peptide ligands for target RNA structures derived from the HIV-1 packaging signal psi by screening phage-displayed peptide libraries.
Pustowka A; Dietz J; Ferner J; Baumann M; Landersz M; Königs C; Schwalbe H; Dietrich U
Chembiochem; 2003 Oct; 4(10):1093-7. PubMed ID: 14523928
[No Abstract] [Full Text] [Related]
10. [Identification of HCV antigen epitopes from a random 15-peptide library by anti-HCV polycloral antibody].
Ke S; Zhu JP; Wen XY; Zhao P; Shi M; He YH; Yao ZJ; Shen BF
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Jan; 19(1):65-7. PubMed ID: 15132911
[TBL] [Abstract][Full Text] [Related]
11. Selection of peptidic mimics of digoxin from phage-displayed peptide libraries by anti-digoxin antibodies.
Ball WJ; Wang Z; Malik B; Kasturi R; Dey P; Short MK; Margolies MN
J Mol Biol; 2000 Aug; 301(1):101-15. PubMed ID: 10926495
[TBL] [Abstract][Full Text] [Related]
12. Identification of peptide ligands to the chemokine receptor CCR5 and their maturation by gene shuffling.
Vyroubalova EC; Hartley O; Mermod N; Fisch I
Mol Immunol; 2006 Apr; 43(10):1573-8. PubMed ID: 16280164
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of the phage display technology for the identification of a hepatitis C virus NS4A epitope recognized early in the course of the disease.
Ferrieu-Weisbuch C; Bettsworth F; Becquart L; Paranhos-Baccala G; Michel S; Arnaud M; Jolivet-Reynaud C
J Virol Methods; 2006 Feb; 131(2):175-83. PubMed ID: 16183141
[TBL] [Abstract][Full Text] [Related]
14. Broadly cross-reactive mimotope of hypervariable region 1 of hepatitis C virus derived from DNA shuffling and screened by phage display library.
Zhang XX; Deng Q; Zhang SY; Liu J; Cai Q; Lu ZM; Wang Y
J Med Virol; 2003 Dec; 71(4):511-7. PubMed ID: 14556263
[TBL] [Abstract][Full Text] [Related]
15. Characterization of prostate-specific antigen binding peptides selected by phage display technology.
Ferrieu-Weisbuch C; Michel S; Collomb-Clerc E; Pothion C; Deléage G; Jolivet-Reynaud C
J Mol Recognit; 2006; 19(1):10-20. PubMed ID: 16312021
[TBL] [Abstract][Full Text] [Related]
16. Identification of hepatitis A virus mimotopes by phage display, antigenicity and immunogenicity.
Larralde OG; Martinez R; Camacho F; Amin N; Aguilar A; Talavera A; Stott DI; Perez EM
J Virol Methods; 2007 Mar; 140(1-2):49-58. PubMed ID: 17129616
[TBL] [Abstract][Full Text] [Related]
17. [Screening of short peptides that bind specifically to osteosarcoma cells by phage-displayed peptide library].
Zhu GH; Liu BY; Zheng SG; Lü H; Shi ZJ
Di Yi Jun Yi Da Xue Xue Bao; 2003 Jan; 23(1):12-5. PubMed ID: 12527505
[TBL] [Abstract][Full Text] [Related]
18. [Epitope mapping of antigenic determinants of hepatitis C virus proteins by phage display].
Rechkina EA; Denisova GF; Masalova OV; Lideman LF; Denisov DA; Lesnova EI; Ataullakhanov RI; Gur'ianova SV; Kushch AA
Mol Biol (Mosk); 2006; 40(2):357-68. PubMed ID: 16637277
[TBL] [Abstract][Full Text] [Related]
19. Selection of tumor-targeting agents on freshly excised human breast tumors using a phage display library.
Shukla GS; Krag DN
Oncol Rep; 2005 Apr; 13(4):757-64. PubMed ID: 15756454
[TBL] [Abstract][Full Text] [Related]
20. ADAM-HCV, a new-concept diagnostic assay for antibodies to hepatitis C virus in serum.
Minenkova O; Gargano N; De Tomassi A; Bellintani F; Pucci A; Fortugno P; Fuscaldi E; Pessi A; Rapicetta M; Miceli M; Iudicone P; Cortese R; Felici F; Monaci P
Eur J Biochem; 2001 Sep; 268(17):4758-68. PubMed ID: 11532012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
